#IDIBELLfellows: Romina Miranda / Marta Valle

07/10/2020 15:00-16:00

Room 205 – Nou aulari UB-Bellvitge
Microsoft Teams Meeting


#IDIBELLconnect: Novel clinical and translational research approaches to mesothelioma, an orphan tumor

Ernest Nadal

Group Leader at Bellvitge Biomedical Research Institute (IDIBELL), Clinical Research in Solid Tumors Group, Oncobell Program
Head of Section of Thoracic, Brain and Head and Neck Tumors, Catalan Institute of Oncology (ICO), Department of Medical Oncology
Associate Professor, University of Barcelona, Department of Clinical Sciences, Campus Bellvitge

09/10/2020 13:00-14:00

Microsoft Teams Meeting


Career Day 2020

21/10/2020 -

21-22 October 2020
This event is being held online


La recerca en temps de pandèmia

Dra. Maria Ángeles Domínguez
Dr. Xavier Solanich

21/10/2020 19:00-

VII Programa de excelencia en el abordaje del paciente con EM de alta actividad

Unitat EM HUB

22/10/2020 -

22-23 Octubre 2020

Sala d’actes Bellvitge University hospital 9.00h


#IDIBELLconnect: RANK a novel therapeutic target in breast cancer

Speaker Eva Gonzalez-Suarez

Transformation and Metastasis Group, Oncobell Program

06/11/2020 13:00-14:00

PhD Day 2020

12/11/2020 -

12-13 November 2020
this event is being held online


#IDIBELLconnect: Generation of protective immunity against infections by removing non-neutralizing/blocking antibodies

Rafael Máñez

Group Leader at the Bellvitge Biomedical Research Institute (IDIBELL), Innate Immunity and Pathology of the Critical Patient Group, Infectious disease and transplantation Program
Director of Intensive Care Department at Bellvitge University Hospital

20/11/2020 13:00-14:00

Microsoft Teams Meeting



Xerrades Sinergia

Òscar Martínez Tirado
Marta Barrachina
Gabriela Jiménez
Anna Veiga
Esteve Fernandez
Susana Jiménez
Rafael Máñez
Mònica Povedano
Miquel Àngel Pujana
Laia Alemany
Montse Nacher

28/11/2020 10:00-19:00

Online i en directe:
https://sinergia.l-h.cat/


#IDIBELLconnect: The mTOR-LARP1 axis and the anabolic reservoir of tumor cells: A new therapeutic target in colorectal cancer and beyond

Antonio Gentilella

Metabolism and Cancer Group, Oncobell Program, Bellvitge Biomedical Research Institute (IDIBELL)
Department of Physiology and Biochemistry, Faculty of Pharmacy, University of Barcelona

04/12/2020 13:00-14:00

Microsoft Teams Meeting


#IDIBELLconnect: Immunotherapeutic potential of oncolytic Vaccinia viruses

Juan Jose Rojas

Bellvitge Biomedical Research Institute (IDIBELL)
Unitat d’Immunologia, Departament de Patologia i Terapèutica Experimental, Universitat de Barcelona

18/12/2020 13:00-14:00

Microsoft Teams Meeting


#IDIBELLseminars: Embryonic origin of cardiac fibroblasts: on and off the record

The epicardium is the outermost tissue layer of the heart. The epicardium forms from the proepicardium (PE),…

Read More

#IDIBELLseminars: C9orf72 FTD/ALS: mechanisms and therapeutic approaches

A GGGGCC repeat expansion in C9orf72 is the most common genetic cause of amyotrophic lateral sclerosis (ALS)…

Read More

#Facultyseminar: Macrophage-epithelial crosstalk and cellular memory govern intestinal regeneration

Jordi Guiu’s laboratory (p-cmrc.cat/research/guiu-group) focuses on understanding the behavior of intestinal epithelial cells during homeostasis and in response…

Read More

Buscando cómo mejorar la movilidad de los pacientes con EspA

Formación continuada en EspA 19 y 20 de diciembre de 2024 Servicio de Reumatologia Hospital Moisès Broggi,…

Read More

Thesis: Unraveling the molecular basis of the metastatic process in Ewing sarcoma: insights into the role of LOXHD1 and PARP14

Friday december 13 2024, Sala de graus de l’Aulari de la UB – Campus Bellvitge, 11:00 h…

Read More

7th ICO-WHO Symposium on tobacco control

Taking decisive action in tobacco control Barcelona, December 9, 2024 Pau Viladiu Auditorium, Catalan Institute of Oncology…

Read More

IDIBELLfellows: Pedro Fuentes & Sara Montserrat

LARP1-Mediated Drug Tolerance in Colorectal Cancer: A Non-Genetic Mechanism Underlying Chemoresistance and Tumor Relapse Pedro Fuentes –…

Read More

Thesis: New therapeutic approaches to target myofibroblast activation in liver pathologies: fibrosis and cholangiocarcinoma

Monday december 16 2024, Sala d’actes, Pavelló de Govern, UB, 11:00 h New therapeutic approaches to target…

Read More

Protein stability and beyond to elucidate hypoxia signaling

“Protein stability and beyond to elucidate hypoxia signaling” Edurne Berra – CICbioGUNE, Bilbao Hosted by Francesc Viñals –…

Read More

Reunión con pacientes con Esclerosis múltiple del hospital de Sant Joan Despí Moisès Broggi

PROGRAMA 16:00 h Introducción a la reunión y bienvenida Dra. Ester Moral, jefa de Servicio de Neurología…

Read More